To amend the Federal Food, Drug, and Cosmetic Act regarding the patient medication information required to be included in the labeling of prescription drugs, and for other purposes.
Patients' Right to Know Their Medication Act of 2023
This bill establishes requirements relating to the form, content, and distribution of patient safety labels for prescription drugs.
Specifically, the Food and Drug Administration must issue regulations with requirements relating to the authorship, content, format, color, printing, and dissemination of such patient safety information. The regulations must require labels to include the drug's approved uses, known interactions with other drugs or substances, contact information for the drug's manufacturer, and other specified information relating to patient safety. The information must be in plain, neutral language and must be given in printed form with each prescription.
Introduced in House
Introduced in House
Referred to the House Committee on Energy and Commerce.
Referred to the Subcommittee on Health.
checking server…
Ask anything about this bill. The AI reads the full text to answer.
Enter to send · Shift+Enter for new line